| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8680560 | Alzheimer's & Dementia: Translational Research & Clinical Interventions | 2017 | 7 Pages |
Abstract
Consideration of the multivariate/joint distribution of components' scores rather than the distribution of a single composite score when designing clinical trials can lead to an increase in power and reduced sample sizes for detecting treatment effects in clinical trials for early AD.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Zhiyue Huang, Graciela Muniz-Terrera, Brian D.M. Tom, Alzheimer's Disease Neuroimaging Initiative Alzheimer's Disease Neuroimaging Initiative,